People · Operator
Named in public records as an officer, director or promoter · active 2023–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Elucid Bioimaging Inc. | — | Biotechnology | Series C | $115.8M | $200.0M | 2023 |
Michael Lesh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Lesh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Scott Huennekens | 1 | 7 |
| Richard Kuntz | 1 | 4 |
| Evan Melrose | 1 | 4 |
| Blake Richards | 1 | 2 |
| Shamiram Feinglass | 1 | 1 |
| Robert Braun | 1 | 1 |
| Andrew J. Buckler | 1 | 1 |
| Rajesh Panda | 1 | 1 |
| Kelly Huang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.